HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-137 Cr | ₹-174 Cr | ₹-292 Cr | ₹-284 Cr | ₹-156 Cr |
What is the latest Cash Flow from Investing Activities ratio of HIKAL ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-137 Cr |
| Mar2024 | ₹-174 Cr |
| Mar2023 | ₹-292 Cr |
| Mar2022 | ₹-284 Cr |
| Mar2021 | ₹-156 Cr |
How is Cash Flow from Investing Activities of HIKAL Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-137 Cr | Negative | |
| Mar2024 | ₹-174 Cr | Negative | |
| Mar2023 | ₹-292 Cr | Negative | |
| Mar2022 | ₹-284 Cr | Negative | |
| Mar2021 | ₹-156 Cr | - | |
Compare Cash Flow from Investing Activities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,569.6 Cr | -1.2% | 13.8% | -47.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,032.0 Cr | 0.9% | 12.8% | 4.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹183,759.0 Cr | 3.2% | 14% | 13.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,224.0 Cr | 0.7% | 5.5% | 36.9% | Stock Analytics | |
| CIPLA | ₹116,214.0 Cr | 6.8% | 18.8% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,739.0 Cr | 0.7% | 5.5% | 9.4% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -1.2% |
13.8% |
-47.8% |
| SENSEX | -3.1% |
-2.8% |
-6.1% |
You may also like the below Video Courses